Inhibitory Effect of Ophthalmic Solutions against SARS-CoV-2: A Preventive Action to Block the Viral Transmission?
Open Access
- 21 July 2021
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 9 (8), 1550
- https://doi.org/10.3390/microorganisms9081550
Abstract
In 2020, a global pandemic was declared following the spread of SARS-CoV-2, the pathogen responsible for COVID-19. The risk of infection is high due to the ease of transmission, which can occur orally, through droplets, or via contact with contaminated surfaces and objects. It has also been demonstrated that the ocular surface can constitute a transmission route, especially in hospital settings, where health care workers can become a dangerous source of infection. In order to increase prevention and reduce the spread of the virus on the ocular surface, the antiviral activity of already-marketed eye drops against SARS-CoV-2 was evaluated. Iodim, Ozodrop, Septavis, and Dropsept were tested against SARS-CoV-2 in plaque-assay experiments at different stimulation times. Furthermore, the expression levels of early and late genes were evaluated through molecular assays. Results indicated that three of the four ophthalmic solutions showed a considerable dose-dependent inhibition of viral replication, highlighting their use as potential antiviral drugs against SARS-CoV-2 and preventing other ocular infections.Keywords
This publication has 54 references indexed in Scilit:
- Altered Patterns of Fungal Keratitis at a London Ophthalmic Referral Hospital: An Eight-Year Retrospective Observational StudyAmerican Journal of Ophthalmology, 2016
- Filamentous fungal infections of the cornea: a global overview of epidemiology and drug sensitivityMycoses, 2015
- Self-assembled or mixed peptide amphiphile micelles from Herpes simplex virus glycoproteins as potential immunomodulatory treatmentInternational Journal of Nanomedicine, 2014
- In vitro efficacy of a povidone–iodine 0.4% and dexamethasone 0.1% suspension against ocular pathogensJournal of Cataract & Refractive Surgery, 2011
- Ozone therapy: A clinical reviewJournal of Natural Science, Biology and Medicine, 2011
- Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activitiesVirology Journal, 2009
- Detection of Virulence Factors in Pseudomonas aeruginosa Strains Isolated From Contact Lens-Associated Corneal UlcersCornea, 2008
- The in vitro effective antiviral action of povidone–iodine (PVP–I) may also have therapeutic potential by its intravenous administration diluted with Ringer’s solutionMedical Hypotheses, 2007
- Inactivation of SARS Coronavirus by Means of Povidone-Iodine, Physical Conditions and Chemical ReagentsDermatology, 2006
- In vitro Virucidal Effectiveness of a 0.12%-Chlorhexidine Gluconate MouthrinseJournal of Dental Research, 1990